General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025 | investorplace.com • |
Atos Secures Top MSCI ESG Rating for Sustainability- TipRanks | news.google.com • |
Atossa Therapeutics names Heather Rees as CFO | proactiveinvestors.com • |
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer | news.google.com • |
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer | globenewswire.com • |
French Stocks: Atos (ATO) Inches Closer to a Restructuring Deal | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-12 | 2024-06 | -0.05 | N/A | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
2023-05-15 | 2023-03 | 0 | -0.05 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
Lesson learned. Never invest in a company where the Scientist also runs the daily operations.
Absolute trash
Trash management. This is what happens when you don’t put business men in charge of running your PR.
Absolute trash
Voting NO unless you give the retail investor some fucking incentive
I’ve learned to always sell this turd every time it spikes up. What a pos
What a turd
Hello twos
I hate this fucking pos
Quay is a fucking joke. Stop trying to build him up. He absolutely sucks at promoting a drug. Brilliant scientist, train wreck at running the face of the company. This will always underperform until you get a competent body in the PR role.
Massive opportunity for the Nasal Spray and still NOTHING. Quay is a freaking joke.
There is literally no attempt to pacify retail investors. They don’t give a shit.
There are no options expiring today
This thing is an absolute turd
Dr. Quay and Mr. Guse will participate in a fireside chat on Monday, August 9, 2021, at 10:00 a.m. ET / 7:00 a.m. PT.
No volume
This stock is trash
What happened to the $3.80 today?
We have no product to sell, therefore no revenue generated. Which means ER will be a nothingburger. How hard is this to comprehend? Stop mentioning “good ER”, there is LITERALLY nothing to drive it.